Surgery Partners Cash Flow Statement
NASDAQ: SGRYHealth CareHospital/Nursing ManagementUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Surgery Partners free cash flow
In fiscal 2025, Surgery Partners generated $274.3 million of operating cash flow and spent $78.7 million on capital expenditures. That left free cash flow of $195.6 million, a free-cash-flow margin of 5.9% of revenue. Free cash flow was down 6.7% from the prior year's $209.7 million.
Summary generated from market data by MetaCap's automated system. Methodology
Surgery Partners cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20162016-12-31 | FY 20152015-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 98.90M | 12.50M | 135.30M | 87.00M | 70.70M | 1.30M | 45.10M | -95.60M | 85.08M | 72.84M |
| Net Income growth (YoY) | +691.20% | -90.76% | +55.52% | +23.06% | +5338.46% | -97.12% | — | -212.36% | +16.80% | — |
| Depreciation & Amortization | 176.00M | 152.60M | 118.10M | 114.80M | 98.80M | 94.80M | 76.50M | 67.40M | 39.55M | 34.55M |
| Stock-Based Compensation | 14.80M | 33.30M | 17.70M | 18.40M | 17.40M | 13.20M | 10.20M | 9.30M | 2.02M | 7.50M |
| Change in Working Capital | -53.80M | -72.10M | -47.20M | -35.30M | -32.10M | -46.60M | -23.50M | -22.80M | -60.62M | -48.78M |
| Operating Cash Flow | 274.30M | 300.10M | 293.80M | 158.80M | 87.10M | 246.90M | 129.50M | 144.60M | 125.24M | 84.48M |
| Capital Expenditures | -78.70M | -90.40M | -88.80M | -80.60M | -57.60M | -42.90M | -73.60M | -39.80M | -39.11M | -33.44M |
| Investing Cash Flow | -246.60M | -488.50M | -225.60M | -307.90M | -331.70M | -88.40M | -85.20M | -128.90M | -184.75M | -134.84M |
| Share Repurchases | — | — | — | — | — | 0 | 0 | -2.00M | 0 | 0 |
| Debt Issued | 1.20B | 1.73B | 826.60M | 217.80M | 299.40M | 429.40M | 506.90M | 282.70M | 650.71M | 196.37M |
| Debt Repaid | -1.04B | -1.28B | -807.10M | -862.00M | -343.20M | -216.30M | -490.80M | -157.60M | -473.44M | -328.33M |
| Financing Cash Flow | -57.30M | 262.00M | -155.20M | 42.10M | 316.30M | 66.70M | -135.90M | -6.30M | 71.28M | 33.37M |
| Net Change in Cash | -29.60M | 73.60M | -87.00M | -107.00M | 71.70M | 225.20M | -91.60M | 9.40M | 11.77M | -16.99M |
| Free Cash Flow | 195.60M | 209.70M | 205.00M | 78.20M | 29.50M | 204.00M | 55.90M | 104.80M | 86.13M | 51.04M |
This table shows 10 annual periods of Surgery Partners's cash flow statement, from FY 2025 back to FY 2015, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow SGRY's reporting calendar. What is a cash flow statement?